Avalo Therapeutics, Inc. · NASDAQ:AVTX

BVF PARTNERS L P/IL reported a 5.30% stake in Avalo Therapeutics, Inc. (Schedule 13G/A)

Event Jun 30, 2026 · Filed Aug 14, 2026

BVF PARTNERS L P/IL reported a 5.30% stake in Avalo Therapeutics, Inc., 2,801,545 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).

Stake
5.30%
Shares
2,801,545
Intent
Passive
What changed
Stake changed
Filed together
10 holders

The filing in full

HolderStakeShares
BIOTECHNOLOGY VALUE FUND L P2.80%1,466,153
BVF I GP LLC2.80%1,466,153
BIOTECHNOLOGY VALUE FUND II LP2.10%1,107,854
BVF II GP LLC2.10%1,107,854
Biotechnology Value Trading Fund OS LP0.40%185,010
BVF Partners OS Ltd.0.40%185,010
BVF GP HOLDINGS LLC4.80%2,574,007
BVF PARTNERS L P/IL5.30%2,801,545
BVF INC/IL5.30%2,801,545
LAMPERT MARK N5.30%2,801,545

Source

View original at SEC

Related